A trial in the United Kingdom is looking at whether or not colchicine, an inexpensive drug used to treat gout, can be effective at treating early stage COVID-19 patients at home. An earlier study out of the Montreal Heart Institute had some encouraging findings, but other researchers are not completely sold on the drug and further investigation is needed to determine how it can affect recovery time and prevent hospitalizations. The government-backed PRINCIPLE trial recently expanded eligibility for the colchicine arm of the trial to include people aged under 50 years.